Epigenetics alternation in lung fibrosis and lung cancer
Respiratory disease including interstitial lung diseases (ILDs) and lung cancer is a group of devastating diseases that linked with increased morbidity and healthcare burden. However, respiratory diseases cannot be fully explained by the alternation of genetic information. Genetic studies described...
Auteurs principaux: | Xueren Li, Chunjing Feng, Shouchun Peng |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Frontiers Media S.A.
2022-11-01
|
Collection: | Frontiers in Cell and Developmental Biology |
Sujets: | |
Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fcell.2022.1060201/full |
Documents similaires
-
Epigenetic Therapy in Lung Cancer
par: Stephen V Liu, et autres
Publié: (2013-05-01) -
Epigenetics as a versatile regulator of fibrosis
par: Yangdan Liu, et autres
Publié: (2023-03-01) -
Progress of Epigenetic Methylation in Lung Cancer Research
par: Shaowei ZHANG, et autres
Publié: (2017-09-01) -
Epigenetic mechanisms and their effects on cancer incidence and treatment: a review study
par: Reyhane Hoshyar, et autres
Publié: (2015-07-01) -
Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
par: Runping Liu, et autres
Publié: (2024-03-01)